Overview of Nucleic Acid Delivery

Driven by the demands of gene therapy, vaccines, and gene editing technologies, nucleic acid delivery technology has become a competitive focus in both global scientific research and industrial sectors. The mainstream nucleic acid delivery methods can be classified into viral vector systems, non-viral vector systems, and physical delivery.

However, nucleic acid drug delivery still faces multiple challenges, and these difficulties limit its wide application.

• Stability and degradation concerns
• Cellular uptake barrier
• Limited targeting specificity
• Inefficient endosomal escape
• Immune reactions risk

LNP Delivery Technology

Lipid Nanoparticle (LNP) technology, as the most advanced nucleic acid delivery system at present, has advantages such as simple operation, modularity, biocompatibility and large loading capacity. LNP efficiently encapsulates nucleic acids through electrostatic interaction, enters cells through endocytosis, and finally releases the nucleic acids into the cytoplasm through endosomal escape to exert their functions.

Our LNP Delivery Kits

To address the challenges of nucleic acid delivery, Protheragen has launched the LNP series of delivery kits, meeting various needs ranging from in vitro research to in vivo applications. Our ready-to-use LNP transfection kits are suitable for the efficient transfection of various nucleic acids such as mRNA and siRNA in cells and animal models.

Our Products' Competitive Advantages

• Rapid encapsulation completes in just one minute
• Cost-effective solution with no expensive equipment required
• Simple operation through easy mixing
• Highly reproducible results
• Efficient loading of various nucleic acids
• Precise targeting capability
• Excellent safety and stability profile
• High transfection efficiency
• Flexible and convenient application

Application Scenario

Our LNP delivery kit series covers the complete range of requirements from basic research to preclinical development, demonstrating great potential in multiple fields:

• Target validation
• Vaccine development
• Nucleic acid drug screening
• Gene editing
• Stem cell therapy
• RNA sequence screening 

Our LNP delivery kits, with their outstanding performance, reliable quality and flexible applicability, are becoming powerful tools for researchers to solve the problem of nucleic acid delivery. Whether you are developing new vaccines or drugs, protein replacement therapies or gene editing treatments, our LNP technology can provide you with reliable and efficient delivery solutions, helping you gain an advantage in fierce market competition. If you are interested in our products, please contact us.